Fujitsu launched a new cloud-based platform that allows users to securely collect and leverage health-related data.
The new platform automatically converts medical data from medical institutions' electronic medical records to conform with the next-generation standards framework HL7 FHIR,
Consenting patients can securely store personal health information such as vital data, step counts, and calorie consumption.
These are converted into non-personally identifiable information on the platform, which supports medical institutions and pharmaceutical companies in performing data analysis and R&D activities.
The new offering represents Fujitsu’s ongoing efforts to promote digital transformation in the medical field and contribute to the creation of a healthy society.
Fujitsu will also use the platform to develop a data portability service that enables patients to view their medical data on their smartphones and allows medical institutions to conduct a highly accurate analysis of shared medical data on the platform.
Fujitsu said it aims to leverage this platform to realize an AI and IoT-based preventive healthcare system and cooperate with various medical institutions and companies to realize a digital health ecosystem.


AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Oil Prices Rise as Hormuz Reopening Remains Uncertain
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
OpenAI Restricts Astra AI Over Cyberattack Risks
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Bets
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
SEC Clears Path for Data Center Securitizations as AI Financing Demand Surges
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk 



